ICU Medical Net Total Equity Issued/Repurchased 2010-2024 | ICUI
ICU Medical net total equity issued/repurchased from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
| ICU Medical Annual Net Total Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $11 |
| 2023 | $4 |
| 2022 | $9 |
| 2021 | $9 |
| 2020 | $13 |
| 2019 | $8 |
| 2018 | $14 |
| 2017 | $31 |
| 2016 | $2 |
| 2015 | $16 |
| 2014 | $14 |
| 2013 | $17 |
| 2012 | $17 |
| 2011 | $-2 |
| 2010 | $-25 |
| 2009 | $-18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $3.371B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||